Pages that link to "Q43265482"
Jump to navigation
Jump to search
The following pages link to Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder (Q43265482):
Displaying 50 items.
- Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review (Q22305514) (← links)
- Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders (Q24187995) (← links)
- NMDA receptors and fear extinction: implications for cognitive behavioral therapy (Q24604822) (← links)
- D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning (Q24626679) (← links)
- Pharmacological treatment of PTSD – Established and new approaches (Q24633256) (← links)
- Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning (Q27001253) (← links)
- Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders (Q27006437) (← links)
- Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (Q27009995) (← links)
- Interoception and learning: import to understanding and treating diseases and psychopathologies (Q27013751) (← links)
- Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks (Q27026213) (← links)
- Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective (Q27026313) (← links)
- Emerging drugs for the treatment of anxiety (Q28083141) (← links)
- D-cycloserine effects on extinction of conditioned responses to drug-related cues (Q28266461) (← links)
- Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. (Q30358603) (← links)
- An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials (Q30375098) (← links)
- Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale (Q30380118) (← links)
- The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders (Q30426498) (← links)
- Chronic antidepressant treatment impairs the acquisition of fear extinction (Q30437449) (← links)
- Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder (Q30459672) (← links)
- Pharmacological enhancement of fear reduction: preclinical models (Q30462825) (← links)
- Glutamate receptors in extinction and extinction-based therapies for psychiatric illness (Q30477927) (← links)
- A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder (Q30498105) (← links)
- A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans (Q30585383) (← links)
- Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis (Q31171981) (← links)
- Novel approaches in treatment of pediatric anxiety (Q33598320) (← links)
- Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke. (Q33708292) (← links)
- D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder (Q33760626) (← links)
- Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive-Compulsive Disorder? (Q33835384) (← links)
- A novel treatment for tinnitus and tinnitus-related cognitive difficulties using computer-based cognitive training and D-cycloserine (Q33912531) (← links)
- Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia (Q33966168) (← links)
- Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder (Q34017493) (← links)
- Effects of D-amino acid oxidase inhibition on memory performance and long-term potentiation in vivo (Q34286452) (← links)
- D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders (Q34350942) (← links)
- Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain (Q34381226) (← links)
- Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions (Q34500045) (← links)
- D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables (Q34562562) (← links)
- Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia (Q34614646) (← links)
- Pharmacological enhancement of drug cue extinction learning: translational challenges (Q34721646) (← links)
- Cognitive enhancers for anxiety disorders (Q35043125) (← links)
- Cognitive enhancers for facilitating drug cue extinction: Insights from animal models (Q35043180) (← links)
- D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis (Q35541703) (← links)
- D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach (Q35715174) (← links)
- Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia. (Q35741322) (← links)
- Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence (Q35897524) (← links)
- Neuroenhancement of Exposure Therapy in Anxiety Disorders (Q35985350) (← links)
- A controlled trial of the adjunct use of D-cycloserine to facilitate cognitive behavioral therapy outcomes in a cocaine-dependent population (Q36005220) (← links)
- Fear extinction and BDNF: translating animal models of PTSD to the clinic (Q36074354) (← links)
- D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis. (Q36304362) (← links)
- The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals (Q36456733) (← links)
- Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? A randomized controlled clinical trial (Q36589135) (← links)